All filters
Slidesets
Comprehensive and multidisciplinary assessment of HIV-infected population aged 60 years or older. Over60 cohort - Dr. E. Negredo
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Developing a ChemSex Care Plan- Dr. D. Stuart
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Value-based healthcare in HIV management – The Economists Perspective- Phil McEwan
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Value-based healthcare in HIV management – The Clinicians’ Perspective- Jean-Jacques Parienti
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Value-based healthcare in HIV management – The Patienst’ Perspective - real life - Kees Brinkman, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Case discussion: Demonstrative cases of social media based HIV and medical non-HIV programs in the community- Guido van den Berk, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Clinical Case Discussion 1- Dr. T.R. Constant Vergara
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Is Baseline Resistance Testing Needed?- Ricardo Diaz, MD
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case Discussion 3- Dr. M.C.Rachid de Lacerda
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
The Role of HIV Integrase Inhibitors in PrEP & PEP- Richard Elion
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
HIV Integrase Inhibitors in an Aging Population (Polypharmacy - Comorbidities)- Dr. M.C.Rachid de Lacerda
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case on Integrase Inhibitors Use in TB-Infected Patients- Dr. L. Grinsztejn
Presented at:
Brazilian HIV Clinical Forum 2017
Meeting
Global HIV Clinical Forum 2017
Slidesets
Basic Science of Integrase Inhibitors - Recent Advances- Francois Clavel, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Potential role of Integrase Inhibitors in resource-limited settings- Gary Maartens, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Resistance Characteristics of Integrase Inhibitors- Charlotte Charpentier, PharmD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Pharmacology related considerations- David Back, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Pediatric use of Integrase Inhibitors- Mark Cotton, MD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Optimal Use of Integrase Inhibitors in Women- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Mutations to Integrase inhibitors in real life- Dr. Isabel Viciana Ramos
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical case of transmitted resistance to HIV Integrase Inhibitors- Dr. Carmen María González Domenech
Presented at:
Global HIV Clinical Forum 2017
Slidesets
The Role of Integrase Inhibitors during HIV prevention- Pep Coll, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Case -Reduced Drug Regimen- Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2017